Clinical Trials Logo

Filter by:
NCT ID: NCT01468961 Completed - Fibromyalgia Clinical Trials

Pilot Study of Internet-based Cognitive Behavior Therapy for Fibromyalgia

Start date: November 2011
Phase: N/A
Study type: Interventional

This pilot trial will include 30-40 participants with a diagnosis of fibromyalgia. The purpose of the study is to evaluate an internet-based treatment protocol based on cognitive behavioral therapeutic principles. Participants are required to have a previous diagnosis of fibromyalgia before entering into the trial. The treatment will be 10 weeks long and all included participants will be given treatment, i.e. there is no randomization to a comparison group.

NCT ID: NCT01468142 Completed - Clinical trials for Respiratory Distress Syndrome, Adult

Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure

Start date: February 2012
Phase: N/A
Study type: Observational

The purpose of this study is the observation of the course of - the mechanics of the respiratory system - the endexpiratory lung volume - and the inflammatory response in patients undergoing treatment with extracorporeal life support (ECLS) due to severe refractory respiratory failure at our department.

NCT ID: NCT01467401 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

Start date: August 19, 2002
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to investigate the efficacy and safety of biphasic insulin aspart (NovoMix®30) to that of biphasic human insulin (Mixtard® 30) in subjects with type 2 diabetes.

NCT ID: NCT01466907 Completed - Stroke Clinical Trials

Secondary Prevention and Health Promotion After Stroke

Start date: February 2008
Phase: N/A
Study type: Interventional

The aim of this study was to examine to what extent a one year population of stroke patients at a university hospital had well regulated risk factors and health problems one year after stroke, and if a structured nurse-led previous follow-up in the intervention group including referrals if needed could influence health outcome and risk factors one year after stroke.

NCT ID: NCT01466660 Completed - Lung Neoplasms Clinical Trials

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Start date: December 13, 2011
Phase: Phase 2
Study type: Interventional

This is a randomised, open-label, phase IIb trial of afatinib to compare to gefitinib in first-line treatment setting with patients who are having epidermal growth factor receptor mutation positive advanced adenocarcinoma of the lung.

NCT ID: NCT01466647 Completed - Clinical trials for Non Small Cell Lung Cancer

A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Start date: January 2011
Phase: Phase 1
Study type: Interventional

This is a open single-center, explorative, Phase I pilot dose finding study including patients treated with AXL1717 in addition to standard chemotherapy of gemcitabine HCL and carboplatin.

NCT ID: NCT01465997 Completed - Epilepsy Clinical Trials

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Start date: May 2012
Phase: Phase 3
Study type: Interventional

Compare safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR) as monotherapy in newly or recently newly diagnosed subjects with primary safety variables including spontaneous reports of Adverse Events (AEs), withdrawal of subjects due to AEs, reporting of Serious AEs (SAEs).

NCT ID: NCT01464476 Terminated - Clinical trials for Cardiovascular Diseases

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)

SHIELD-2
Start date: November 2011
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of Azimilide on the incidence of cardiovascular hospitalizations, cardiovascular emergency department visits or cardiovascular death in patients with Implantable Cardioverter Defibrillators (ICDs)

NCT ID: NCT01463137 Completed - Social Phobia Clinical Trials

Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder

SOFIE-11
Start date: October 2011
Phase: N/A
Study type: Interventional

A study investigating six different versions of a computerized attention bias modification internet program in the treatment of social phobia / social anxiety disorder.

NCT ID: NCT01463020 Completed - Depression Clinical Trials

Behavioural Activation-Based Treatment Administered Through Smartphone

Start date: February 2012
Phase: N/A
Study type: Interventional

The objective is to test the effects of a smartphone-delivered behavioural activation treatment. Also, a moderator analysis of low and high severity of depressive symptoms will be made. We expect the behavioural activation intervention to be superior to the mindfulness intervention for the participants suffering from high severity of depressive symptoms - and the mindfulness intervention to be better or at least as good as the behavioural activation intervention for the participants suffering from low severity of depressive symptoms.